Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy

被引：27

作者：

Krause, AS ^{[1
]}

Weihrauch, MR ^{[1
]}

Bode, U ^{[1
]}

Fleischhack, G ^{[1
]}

Elter, T ^{[1
]}

Heuer, T ^{[1
]}

Engert, A ^{[1
]}

Diehl, V ^{[1
]}

Josting, A ^{[1
]}

机构：

[1] Univ Cologne, Dept Internal Med 1, Cologne, Germany

来源：

LEUKEMIA & LYMPHOMA | 2002年 / 43卷 / 11期

关键词：

MTX; carboxypeptidase; lymphoma; rescue;

D O I：

10.1080/1042819021000032953

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

High-dose methotrexate (RDMTX) is a component of many cancer treatment regimens. Despite careful management, delayed renal clearance, followed by extremely high serum levels with potentially life-threatening toxicity can occur. In the present study, we report our results of carboxypeptidase-G(2) (CPDG(2)) rescue in 8 patients with delayed methotrexate elimination and renal impairment after HDMTX therapy for lymphoma or osteosarcoma. A dose of 50U/kg CPDG2 was administered. MTX plasma levels decreased rapidly and recovery of renal function was observed in all patients. No patient developed severe WHO grade 4 MTX toxicity. CPDG2 provides an alternative route of MTX elimination by converting it to inactive and non-toxic metabolites. CPDG(2), rescue was well tolerated, safe and very effective in preventing severe or life-threatening MTX toxicity.

引用

页码：2139 / 2143

页数：5

共 50 条

[21] 2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity
Berga, Francisco
Luna, Pablo
Martorell, Clara
Rey, Juan
Gomila, Isabel
Gimenez, Sandra
Costa-Bauza, Antonia
Angel Elorza, Miguel
Sanchez, Iolanda
Grases, Felix
Barcelo, Bernardino
CLINICA CHIMICA ACTA, 2018, 487 : 1 - 5
[22] PHARMACOKINETICS OF METHOTREXATE AND 7-HYDROXY-METHOTREXATE AFTER HIGH-DOSE (33.6 G/M2) METHOTREXATE THERAPY
SLORDAL, L
KOLMANNSKOG, S
PRYTZ, PS
MOE, PJ
AARBAKKE, J
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1986, 3 (02) : 127 - 134
[23] GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-DOSE METHOTREXATE TOXICITY
Ramos Jesus, Ruiz
Aguado Jorge, Reig
Cava Paloma, Escobar
Briz Eduardo, Lopez
Jose Luis, Poveda Andres
ATENCION FARMACEUTICA, 2013, 15 (04): : 295 - 298
[24] METHOTREXATE AND METHOTREXATE POLYGLUTAMATES IN HUMAN SARCOMA METASTASES AFTER HIGH-DOSE METHOTREXATE THERAPY
SCHALHORN, A
SAUER, H
WILMANNS, W
STUPPPOUTOT, G
KLINISCHE WOCHENSCHRIFT, 1983, 61 (21): : 1089 - 1094
[25] FERROKINETICS AFTER HIGH-DOSE METHOTREXATE THERAPY
SCHALHORN, A
SAUER, H
WILMANNS, W
STUPPPOUTOT, G
KLINISCHE WOCHENSCHRIFT, 1981, 59 (19): : 1109 - 1113
[26] A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy
Ishizaki, Junko
Nakano, Chihiro
Kitagawa, Kana
Suga, Yukio
Sai, Yoshimichi
ANNALS OF PHARMACOTHERAPY, 2020, 54 (01) : 29 - 35
[27] SAFETY OF DELAYED LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE IN CHILDREN
CAMITTA, BM
HOLCENBERG, JS
MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 5 : 55 - 59
[28] SEVERE UNEXPECTED IMPAIRMENT OF RENAL METHOTREXATE ELIMINATION AFTER HIGH-DOSE THERAPY
LAWRENZWOLF, B
WOLFROM, C
FRICKEL, C
FENGLER, R
WEHINGER, H
HENZE, G
KLINISCHE PADIATRIE, 1994, 206 (04): : 319 - 326
[29] BIOCHEMICAL CONTROL OF HIGH-DOSE METHOTREXATE LEUCOVORIN RESCUE THERAPY
WILMANNS, W
SAUER, H
SCHALHORN, A
RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 42 - 49
[30] HIGH-DOSE METHOTREXATE THERAPY
BELL, R
SULLIVAN, JR
MOON, WJ
HURLEY, TH
MEDICAL JOURNAL OF AUSTRALIA, 1977, 1 (08) : 247 - 249

← 1 2 3 4 5 →